ATRIP and breast carcinoma: Overall, our report reinforces the emerging concept that ATRIP contributes to hereditary breast cancer predisposition and highlights the need for further research to refine risk estimates, strengthen mechanistic understanding, and guide clinical management of individuals harboring ATRIP deleterious variants.